Please login to the form below

Not currently logged in
Email:
Password:

Dr Ian Hudson elected vice chair of CHMP

Will serve a three-year term on EMA's scientific advisory committee

MHRA CHMP Dr Ian HudsonThe EMA's Committee for Medicinal Products for Human Use (CHMP) has elected Dr Ian Hudson to serve as its vice chair for a three-year term.

Dr Hudson has been a member of the scientific advisory committee since 2004 and is currently director of the licensing division at UK medicines regulator the MHRA.

Announcing its appointment the EMA said: “Dr Hudson brings outstanding experience and expertise from a long career in regulatory medicine and drug development, particularly in the areas of anti-infectives and oncology.”

Before joining the MHRA in 2001 Dr Hudson worked in the pharmaceutical industry for 12 years, during which time he held various clinical research and development positions at SmithKline Beecham. Prior to this he worked in clinical practice as a paediatrician.

22nd October 2012

From: Research, Sales, Regulatory

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...

Infographics